Results

Total Results: 1,161 records

Showing results for "patient safety".

321. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Although propofol may be preferred for these reasons, safety concerns complicate its use. … The intent is to improve seniors’ safety, clinical outcomes, and quality of care and to reduce admissions … the Sedasys can be used.7 The FDA approval requires that EES conduct two postmarketing studies on safety … Clinicians can access objective, accurate, and timely data about patient adherence, to monitor patients … It may be 12 solely age-based (i.e., patients 65 years and older) or also based on patient complaint

322. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - patient safety and care … safety and care. … A diagnosis could, however, help patients and families plan for the patient’s care and safety. … Furthermore, experts thought that the drug’s well-known safety profile and long history of use (in … AD patients.

323. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - • Population(s): - For KQ1, all patients with, or at risk for, osteoporotic fractures (or who meet … - Subgroups of patients are considered in KQ2. … Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety- RelatedDrugLabelingChanges … /MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm122109.htm� http://www.fda.gov/Safety … /MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm122109.htm� http://www.fda.gov/Safety

324. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - What are the patient-level and intervention-level characteristics associated with RFA effect on short … Safety surveillance alerts (Cycle 2): No relevant safety alerts. 1st assessment conclusion (Cycle 1 … Safety surveillance alerts (Cycle 2): No relevant safety alerts. 1st assessment conclusion (Cycle 1 … Safety surveillance alerts (Cycle 2): No relevant safety alerts. 1st assessment conclusion (Cycle 1 … Safety surveillance alerts (Cycle 2): No relevant safety alerts. 1st assessment conclusion (Cycle 1

325. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
     April 01, 2012 - In a clinical trial, the effectiveness and safety of BT versus a sham procedure in patients (n = 288) … Thermoplasty System for treatment-resistant asthma studies to investigate the system’s long-term safety … Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter … PMA P080032: FDA summary of safety and effectiveness data (SSED) for the Alair bronchial thermoplasty … Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: research

326. AHRQ's Evidence-based Practice Center Division Annual Report 2021: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
     January 01, 2021 - Safety of vaccines used for routine immunization in the United States: An updated systematic review … Increasing out-of-pocket costs for neurologic care for privately insured patients. … National Highway Traffic Safety Administration (NHTSA) 5. … Agency for Healthcare Research and Quality (AHRQ) - Center for Quality Improvement and Patient Safety … Patient-Centered Outcomes Research Institute (PCORI) 14.

327. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
     June 01, 2010 - It is unfair to label all companies as profit-driven over safety- driven. … Same page, line 56: Patient should be plural. … basis, these direct-to patient distribution channels are only used for patients with hemophilia or … Further, this trial was designed primarily as a safety and proof-of- concept trial. … For example, there are reasons to believe that certain patient populations (e.g., older patients and

328. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
     June 01, 2010 - associated with preterm birth represent untold distress for families, as well as significant costs to patients … 17-OHP treatment regimen is relatively modest; one study estimates it to be about $400 per treated patient … Adherence is influenced by the timing, dose, route, and interval of the progestogen given, patient factors … Adverse events may occur at any point after the treatment is received, and are affected by patient factors … factors such as specialty, and health care system factors such as cost and availability, as well as patient

329. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
     October 12, 2015 - KQ 1: What are the comparative safety and effectiveness of available treatment strategies for women … KQ 2: What are the comparative safety and effectiveness of available treatment strategies for women … KQ 3: What are the comparative safety and effectiveness of available treatment strategies for women … KQ 4: What are the comparative safety and effectiveness of available treatments for women with tubal … Safety of assisted reproductive technology in the United States, 2000-2011.

330. Disposition of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-disposition-comments.pdf
     August 20, 2024 - • Patients with older age, immunocompromised status, and minoritized racial/ethnic identity were … A question was raised about what evidence should be used to support decision making for these patient … Providing standard of care to minoritized patients is important based on best available evidence. … (excluded in most trials) versus immunocompetent patients because of varying treatment tolerability … 5FU”; And suggest to add something like “we need well designed real world data on the efficacy and safety

331. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - How do the efficacy, effectiveness, safety, and adverse effects of treatment with DMARDs differ among … How do the efficacy, effectiveness, Insufficient Only one study—an RCT of methotrexate versus safety, … In addition, patient-level meta-analysis may help address this challenge. … • The need for study populations who are representative of typical patients with JIA. … Randomized discontinuation trials have helped to define the risk of flare in patients who respond to

332. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - In secondary analyses, we explored a broader patient population by including those studies that had … Insufficient 13 studies (9 good quality, 4 fair) reported data pertinent to safety concerns or risks … Study results on these issues were reported for the total patient population and did not separate the … Third, most studies lacked long-term followup of the patient population, which affected our ability … Reporting of risk, harms, and/or safety outcomes.

333. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Using the system would represent a way to purportedly enhance patient mobility and allow patients to … fumarate because of the efficacy and safety profile reported in patients with RRMS, the experts thought … Regarding acceptance by both patients and clinicians, one clinical expert commented, “The safety profile … Experts generally agreed that potential patient adoption would be high because of patients’ desire to … One research expert opined that elderly patients may have more reservations than a younger patient

334. S89 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
     October 01, 2007 - Key Words: vaccine safety, active surveillance, sequential analysis, meningococcal vaccine, drug safety … occurred since the beginning of the study period in the following strata: calendar week of observation, patient … It could be useful not only in vaccine safety studies, but also during drug safety monitoring, when analysts … We are currently assessing the use of maxSPRT in drug safety monitoring.18 Drug safety studies entail … Vaccine safety monitoring.

335. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
     January 01, 2012 - with the underlying disease and its severity, general health status or frailty, quality of life, and patient … A comparison between aripiprazole, an antipsychotic agent with a relatively favorable metabolic safety … treated with the oral dosage form mainly due to the different way of administering the drugs (patient … It is common that information about the patient, exposure or comparison treatment, and/or outcome is … does not necessarily remove confounding by severity.21 For clinical effectiveness or safety questions

336. Systematic Review on Treatments for Acute Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-2-acute-pain.pdf
     May 01, 2022 - Patient Education as Topic/ A-8 34. … How do harms vary depending on: (1) patient demographics (e.g., age, gender); (2) patient medical or … How do harms vary depending on: (1) patient demographics (e.g., age, gender); (2) patient medical comorbidities … How do harms vary depending on: (1) patient demographics (e.g., age, gender); (2) patient medical and … safety and pain management: a systematic review and meta-analysis.

337. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and services … Effectiveness and Safety of Drug- Eluting Stents in Ontario. … Balancing Efficacy and Safety of Drug-Eluting Stents in Patients Undergoing Percutaneous Coronary … Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents. … Unadjusted baseline characteristics of patients in study population Patient Characteristics Study

338. S81 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
     October 01, 2007 - Key Words: hierarchically optimal classification tree analysis, patient safety indicators, surveillance … The Agency for Health- care Research and Quality (AHRQ) has developed 20 pro- vider-level patient safety … AHRQ Quality Indica- tors—Guide to Patient Safety Indicators. … Discriminating geriatric and nongeriatric patients using functional status information: an example of … Tracking rates of patient safety indicators over time: lessons from the Veterans Administration.

339. Evaluation of Mental Health Applications (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
     January 01, 2018 - of mental health apps, causes providers to be hesitant about recommending apps.7 Most providers and patients … researchers, health care providers, informaticians and technologists, app developers, as well as patient … We plan to have a separate call for patient/caregiver KI at the start of the project, with questions … /clients and health care providers; security and privacy features such as data usage and sharing of … how it works, how it is currently used or might be used, and which features may be important from a patient

340. Management of Suicidal Thoughts and Behaviors in Youth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-draft-protocol.pdf
     March 14, 2024 - regulation and management, behavioral planning, family engagement and communication training, and practical safety … intervals), directness of the evidence to the KQs (focusing on whether the outcomes were important to patients … Intervention research with persons at high risk for suicidality: safety and ethical considerations. … The SAFETY program: a treatment-development trial of a cognitive-behavioral family treatment for adolescent … Key Informants Key Informants are the end-users of research; they can include patients and caregivers